Using extended cognitive behavioral treatment and medication to treat dependent smokers

American Journal of Public Health

Volumn 101, Issue 12, 2011, Pages 2349-2356

  Hall, Sharon M ^a   Humfleet, Gary L ^a   Muñoz, Ricardo F ^a   Reus, Victor I ^a   Prochaska, Judith J ^a   Robbins, Julie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DOPAMINE UPTAKE INHIBITOR; NICOTINE GUM;

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; BUPROPION; COGNITIVE THERAPY; COUNSELING; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 81555222567     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2010.300084     Document Type: Article

References (23)

1. The Tobacco Use and Dependence Clinical Practice Guideline panel, staff, and consortium representatives. A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. JAMA. 2000;283(24):3244-3254.
2. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Dept of Health and Human Services, Public Health Service; 2008.
3. Hays JT, Hurt RD, Rigotti N, et al. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med. 2001;135(6):423-433. (Pubitemid 32845867)
4. Hurt RD, Krook JE, Croghan IT, et al. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol. 2003;21(5):914-920. (Pubitemid 46606452)
5. Cox LS, Patten CA, Niaura RS, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med. 2004;19(8):828-834. (Pubitemid 39096354)
6. Williams KE, Reeves KR, Billing CB Jr, Pennington AM, Gong J. A double-blind study evaluating the longterm safety of varenicline for smoking cessation. Curr Med Res Opin. 2007;23(4):793-801. (Pubitemid 46646499)
7. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):64-71.
8. Killen JD, Fortmann SP, Murphy GM, et al. Extended treatment with bupropion SR for cigarette smoking cessation. J Consult Clin Psychol. 2006;74(2):286-294. (Pubitemid 43807361)
9. Killen JD, Fortmann SP, Schatzberg AF, et al. Extended cognitive behavior therapy for cigarette smoking cessation. Addiction. 2008;103(8):1381-1390. (Pubitemid 352009055)
10. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ. Extended treatment of older cigarette smokers. Addiction. 2009;104(6):1043-1052.
11. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134(8):663-694. (Pubitemid 32322245)
12. Jacob P, Hatsukami D, Severson H, Hall S, Yu L, Benowitz NL. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1668-1673. (Pubitemid 36020022)
13. McNair DM, Lorr M, Droppleman LF. Manual: Profile of Mood States (POMS). San Diego, CA: Educational and Industrial Testing Service; 1971.
14. Hall SM, Havassy BE, Wasserman DA. Effects of commitment to abstinence, positive moods, stress, and coping on relapse to cocaine use. J Consult Clin Psychol. 1991;59(4):526-532.
15. Ware JE, Sherbourne CD. The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-483.
16. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401.
17. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289-294. (Pubitemid 16052281)
18. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381-1395. (Pubitemid 36936159)
19. Hall SM, Muñoz RF, Reus VI, et al. Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo controlled study. J Consult Clin Psychol. 1996;64(5):1003-1009. (Pubitemid 26349579)
20. Muñoz RF, Marín BV, Posner SF, Pérez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. Am J Community Psychol. 1997;25(3):325-343. (Pubitemid 127714774)
21. Hall SM, Tunstall CD, Vila KL, Duffy J. Weight gain prevention and smoking cessation: cautionary findings. Am J Public Health. 1992;82(6):799-803.
22. Hall SM, Humfleet GL, Reus VI, Muñoz RF, Cullen J. Extended nortriptyline and psychological treatment for cigarette smoking. Am J Psychiatry. 2004;161(11):2100-2107. (Pubitemid 39441412)
23. Ossip-Klein DJ, Carosella AM, Krusch DA. Self-help interventions for older smokers. Tob Control. 1997;6(3):188-193. (Pubitemid 127685523)